argenx

📍 Boston, United States🗓 Founded 2008👥 1,709 employees💰 Last funded 2009
Biotechnology Research🌐 argenx.com
Website LinkedIn
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Netherlands
1
Belgium
1
Frequently asked questions
Who invested in argenx?
argenx has 2 investors on record on gritt.io, including 2 early-stage backers.
When did argenx last raise funding?
The most recent investment in argenx recorded on gritt.io was in 2009.
When was argenx founded?
argenx was founded in 2008.
What industry is argenx in?
argenx operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is argenx based?
argenx is headquartered in Boston, United States.